Free public records show Imediplus, Inc. in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Imediplus, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Imediplus, Inc. is in.
Stories on the topics Imediplus, Inc. works in.
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
Read
Patch pumps stick to the skin and deliver insulin without tubes. In August 2024, the FDA cleared the first…
Read
589 million adults live with diabetes, a number set to reach 853 million by 2050. Devices are changing how…
Read